Navigation Links
VIA Pharmaceuticals to Present at Susquehanna and Rodman & Renshaw Conferences on March 4, 2008
Date:2/26/2008

SAN FRANCISCO, Feb. 26 /PRNewswire-FirstCall/ -- VIA Pharmaceuticals, Inc. (Nasdaq: VIAP), a biotechnology company focused on the development of compounds for the treatment of cardiovascular disease, announced today that James G. Stewart, senior vice president, chief financial officer of VIA, will present a company update at the Susquehanna Second Annual SIGnificant Options in Healthcare on Tuesday, March 4, 2008, at 1:30 p.m. ET at the W Hotel in New York. Interested parties may access a live audio webcast of the presentation from the investor section of the VIA website, http://www.viapharmaceuticals.com. A replay of the presentation will be archived on the site for at least one week following the presentation.

Also on March 4, Lawrence K. Cohen, Ph.D., chief executive officer of VIA, will be speaking at the Rodman & Renshaw Straight to the Heart Cardiovascular Investor Mini Conference in Boston, at the Boston Harbor Hotel.

About VIA Pharmaceuticals, Inc.

VIA Pharmaceuticals, Inc. is a biotechnology company focused on the development of compounds for the treatment of cardiovascular disease. VIA is building a pipeline of small-molecule drugs that target a significant unmet medical need: reducing inflammation in the blood vessel wall, which is an underlying cause of atherosclerosis and its complications, including heart attack and stroke. The company's lead drug candidate, VIA-2291, is in multiple Phase 2 clinical studies in patients with cardiovascular disease. For more information, visit: http://www.viapharmaceuticals.com.


'/>"/>
SOURCE VIA Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. Lotus Pharmaceuticals Raises $5 Million in Private Placement
2. Galderma Reaches Agreement to Acquire CollaGenex Pharmaceuticals
3. Transcept Pharmaceuticals to Present at the Susquehanna Financial Groups SIGnificant Investment Options in Healthcare Conference
4. Onyx Pharmaceuticals Reports Fourth Quarter and Twelve-Month 2007 Financial Results
5. RHEI Pharmaceuticals Licenses Attental From MethaPharma (Vemedia Group) for Distribution Throughout Asia
6. Onyx Pharmaceuticals Announces a Teleconference and Webcast to Provide an Update on Nexavar; Previously Announced Fourth Quarter and Full Year 2007 Financial Results Teleconference Rescheduled
7. NUCRYST Pharmaceuticals announces year-end results
8. Renhuang Pharmaceuticals, Inc. Retains CCG Elite
9. MiddleBrook Pharmaceuticals Engages Morgan Stanley in Its Strategic Process
10. Watson Pharmaceuticals Announces FDA Inspection of Florida Facilities
11. American Association of Clinical Endocrinologists and North American Menopause Society Fail to Disclose Financial Ties to Wyeth Pharmaceuticals

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...ench and Spanish . , Researchers at the U...alled ,gene E, which leads to the death of tumour... and prevents their growth. The importance of this...ce the potent drugs that are currently used, so th... , This research was conducted by Ana Rosa Rama...
(Date:11/24/2009)...rman . , Internationally viewed, medical car... as far as survival is concerned. However, other a...rm consequences of the disease are still insuffici...ion of the Institute for Quality and Efficiency in... on 16 October 2009. , Establish mandatory qual...
(Date:11/24/2009)...lastic surgery experts from the American Society o...s the recently proposed cosmetic surgery tax. , ...s) November 24, 2009 -- Leading plastic surgery ex...s (ASPS), are available to discuss the recently pr...e nation’s leading plastic surgery experts a...
(Date:11/24/2009)...th undesirable blood levels, analysis shows , ...mal cholesterol levels can significantly increase ..., U.S. researchers analyzed data on 6,860 parti...titute,s Framingham Heart Study. None of the parti...e at the start of the study. After about 26 years ...
(Date:11/24/2009)...evice regulatory consulting firm Emergo Group rece..., distributors and industry service providers abou...ion plans and their outlook for 2010. , ...2009 -- Global medical device regulatory consulti...al device and IVD manufacturers, distributors and ...
Breaking Medicine News(10 mins):Health News:Gene increases effectiveness of drugs used to fight cancer and allows reduction in dosage 2Health News:In Germany, children with cancer have a high probability of survival 2Health News:In Germany, children with cancer have a high probability of survival 3Health News:Leading Plastic Surgery Experts Available to Discuss Proposed ,Cosmetic Surgery Tax 2Health News:Cholesterol Plays Role in Heart Failure Risk 2Health News:Medical Device Industry Positive About 2010 – Survey 2
...n proposed by researchers at Medical College of Wi... assess the improvement in survival rate in cardia... The study would be funded by the National Heart...ardiac arrest and severe traumatic injury, and wou...
...ropean breast cancer conference (EBCC-5) had docto...st cancer research and improve patient care//. Bre...n women. But as of now the survival rates are impr...ation for Research and Treatment of Cancer (EORTC)...
...to the study conducted by Theodore Blaine, M.D., a...bia University Medical Center and an attending// s...aluronate, a drug that is FDA-approved for osteoar...other Cox-2 inhibitors. After that people went for...
...ts suffering from chronic shoulder pain were left ...dvil or to go for a surgery//, after the safety co...s were raised. But a research done by Columbia Uni... the shoulder pain. The study was presented ...
...g maker Sanofi-Aventis SA announced on Thursday th...d its cancer drug Taxotere to treat patients with ...e can be used in combination with chemotherapy dru...es of breast cancer and lung cancer. Certain types...
...rs believe that enforced bicycle helmet laws impro...this view aside.// Several studies suggest t... head injuries than non-wearers. But Dorothy Robin...e public health. She reviewed data from coun...
Other Medicine News:Health News:An Effective Drug Identified for Shoulder Pain 2Health News:New Drug For Treating Chronic Shoulder Pain 2Health News:New Drug For Treating Chronic Shoulder Pain 3Health News:Can Enforcing Bicycle Helmet Laws Avoid Head Injuries? 2
(Date:11/24/2009)...RNewswire/--MAQUETCardiovascularLLC,aleadingprovid...thassignedaguaranteedtwo-yearcontractwithNovation,...s,tobethesolesourceproviderofsurgicaldevicesforbea...greement,whichrunsthroughOctober31,2012,MAQUETCard...devicesanddisposablesuppliestothemembersofVHAInc.a...
(Date:11/24/2009)...ewswire-FirstCall/--Orexigen®Therapeutics,Inc...nthetreatmentofobesity,todayannouncedthatonNovembe...dofDirectorsgrantedaninducementstockoptiontopurcha...itsnewlyappointedHeadoftheGlobalContraveProgram. ,...ptiontotheextentpermittedbylawandhasanexercisepric...
(Date:11/24/2009)...4/PRNewswire-FirstCall/--BioSpecificsTechnologiesC...opingfirstinclasscollagenase-basedproducts,todayan...esentattheupcomingPiperJaffray21stAnnualHealthCare...NewYorkPalaceHotelinNewYork,NY. ,, Alivewebcast...ts"intheInvestorRelationssectionoftheCompany,swebs...
Breaking Medicine Technology:MAQUET Cardiovascular Receives Guaranteed Two-Year Sole Source Contract From Novation for Beating Heart Surgical Devices 2MAQUET Cardiovascular Receives Guaranteed Two-Year Sole Source Contract From Novation for Beating Heart Surgical Devices 3Orexigen(R) Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) 2Orexigen(R) Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) 3Empire BlueCross BlueShield Launches Art Heals Program with Museum for African Art Greater New York Hospital Association 59161 1Empire BlueCross BlueShield Launches Art Heals Program with Museum for African Art Greater New York Hospital Association 59161 2Empire BlueCross BlueShield Launches Art Heals Program with Museum for African Art Greater New York Hospital Association 59161 3Producers of New PBS Series Joined By Experts to Reveal Science Behind Happiness 59158 1Producers of New PBS Series Joined By Experts to Reveal Science Behind Happiness 59158 2Producers of New PBS Series Joined By Experts to Reveal Science Behind Happiness 59158 3Producers of New PBS Series Joined By Experts to Reveal Science Behind Happiness 59158 4Producers of New PBS Series Joined By Experts to Reveal Science Behind Happiness 59158 5Greenway Medical Technologies Continues to Lead the Evolution of Healthcare Automation at National Health IT Week in Washington D C 5345 1Greenway Medical Technologies Continues to Lead the Evolution of Healthcare Automation at National Health IT Week in Washington D C 5345 2Greenway Medical Technologies Continues to Lead the Evolution of Healthcare Automation at National Health IT Week in Washington D C 5345 3Greenway Medical Technologies Continues to Lead the Evolution of Healthcare Automation at National Health IT Week in Washington D C 5345 4
...April 27 Pomegranate juice may slow the progres... according to new long-term research results being...of the American Urological Association (AUA). Rese...t for localized prostate cancer could benefit from...clinical trial followed a total of 48 participants...
...(R) System Capabilities Enable Powerful New TB Dia...heid (Nasdaq: CPHD ) today announced the release...r the European Directive on In Vitro Diagnostic ...icians will have access to a rapid test that can s... (MTB) and resistance to rifampicin (RIF), a comm...
Other Medicine Technology:Men Treated for Localized Prostate Cancer Could Benefit From Pomegranate Juice Consumption 2Cepheid Announces European Release of First On-Demand Molecular Test for Simultaneous Detection of Mycobacterium tuberculosis (TB) and Resistance to Rifampicin 2Cepheid Announces European Release of First On-Demand Molecular Test for Simultaneous Detection of Mycobacterium tuberculosis (TB) and Resistance to Rifampicin 3Cepheid Announces European Release of First On-Demand Molecular Test for Simultaneous Detection of Mycobacterium tuberculosis (TB) and Resistance to Rifampicin 4Cepheid Announces European Release of First On-Demand Molecular Test for Simultaneous Detection of Mycobacterium tuberculosis (TB) and Resistance to Rifampicin 5Cepheid Announces European Release of First On-Demand Molecular Test for Simultaneous Detection of Mycobacterium tuberculosis (TB) and Resistance to Rifampicin 6
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
Medicine Products: